Peanut allergies: treatment pathways and options
About this session
Managing peanut allergies requires a tailored approach, ranging from strict avoidance and emergency preparedness to therapies such as oral immunotherapy (OIT) and biologics. This session discusses the latest treatment options, their effectiveness, and how to personalize management plans for patients.
Ludger Klimek
Dr. Ludger Klimek is a distinguished specialist in allergology and clinical immunology. He leads the Center for Rhinology and Allergology in Wiesbaden and holds a professorship in special rhinology, allergology, and environmental medicine at the Medical Faculty Mannheim of Heidelberg University. Dr. Klimek serves as president of the German Society of Allergology (AeDA) and the German Allergy League. He is also the national coordinator for Germany in the World Health Organization's ARIA (Allergic Rhinitis and its Impact on Asthma) initiative and board member of the ENT Section of the European Academy of Allergy and Clinical Immunology.
His research focuses on allergic rhinitis, allergen-specific immunotherapy, and component-resolved diagnostics. Dr. Klimek has authored several influential publications, including studies on the benefits of molecular allergen diagnostics in allergic rhinitis and the role of allergen-specific immunotherapy in oral allergy syndrome.
Related sessions
Peanut components in practice: diagnosing peanut allergy
Introduction to component-resolved diagnostics in allergy
From dust to pollen: exposure to the most common airborne allergens
Climate change and the impact on pollen allergies
Singleplex allergy diagnostic assays: Are they comparable?
AllergoOncology
